This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
Congratulations to Rebel Curd and David Kemp for their recent recognition as “highly regarded” leaders in International Tax Review’s (ITR) 2025 World Tax...
CRA is pleased to be acknowledged in International Tax Review’s (ITR) 2025 World Transfer Pricing Guide as one of the “leading” transfer pricing practices in...
CRA is a proud sponsor of the event. Anna Soubbotina is a panelist during the session titled “The essential global transfer pricing developments to be aware...
CRA is a proud sponsor of the conference bringing together speakers and attendees from around the world discussing leading edge topics relevant to high tech...
